CytomX Therapeutics to Present at Upcoming November Investor Conferences

On November 11, 2021 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated therapeutics, reported that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in virtual fireside chats at the following investor conferences in November (Press release, CytomX Therapeutics, NOV 11, 2021, View Source [SID1234595242]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

12th Annual Jefferies Global Healthcare Conference
Date: Thursday, November 18, 2021

33rd Annual Piper Sandler Virtual Healthcare Conference
Date: Tuesday, November 30, 2021

The Jefferies fireside chat will be made available at 3:00 a.m. ET (8:00 a.m. GMT) on Thursday, November 18, 2021 on the Events and Presentations page of CytomX’s website at www.cytomx.com. The Piper Sandler fireside chat will be made available at 10:00 a.m. ET on Monday, November 22, 2021. Archived replays of both fireside chats will be available on the CytomX website for 30 days following the event. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.